BioXcel Therapeutics (BTAI) Inventory Average (2022 - 2026)

BioXcel Therapeutics' Inventory Average history runs 5 years deep, the most recent figure standing at $611000.0 for Q1 2026.

• In Q1 2026, Inventory Average fell 7.49% year-over-year to $611000.0; the TTM figure through Mar 2026 stood at $611000.0 (down 7.49% YoY), while the FY2025 annual figure was $700500.0, down 47.53% from the prior year.
• Inventory Average was $611000.0 for Q1 2026 at BioXcel Therapeutics, up from $590500.0 in the prior quarter.
• In the past five years, Inventory Average ranged from a high of $2.6 million in Q2 2024 to a low of $482500.0 in Q3 2025.
• Historically, Inventory Average has averaged $1.4 million across 5 years, with a median of $1.5 million in 2022.
• The sharpest annual moves came in 2023 and 2025: Inventory Average surged 86.66% in 2023, then slumped 77.57% in 2025.
• A 5-year view of Inventory Average shows it stood at $1.7 million in 2022, then gained by 18.16% to $2.0 million in 2023, then slumped by 45.02% to $1.1 million in 2024, then tumbled by 46.42% to $590500.0 in 2025, then rose by 3.47% to $611000.0 in 2026.
• The last three Inventory Average figures came in at $611000.0 (Q1 2026), $590500.0 (Q4 2025), and $482500.0 (Q3 2025), per Business Quant data.